E-WorkBook Suite 8.2 includes enhancements to multistep chemical pathway generation, rendering and searching, which are of particular importance in metabolite identification and process optimization. A ‘Print To’ function, increased data exchange capabilities and enhanced analytical data capture and visualization are all features that scientists in the areas of method development and validation describe as class-leading.
The UK-based firm claimed that the new version provides enhanced support for controlled data entry processes, easier and faster data entry and analysis, and intellectual property (IP) protection capabilities.
Ruchi Mallya, analyst for pharmaceutical technology at Ovum, said: We are seeing a unique and important shift in the pharma and biotech industries where companies are moving from a document-centric view of the enterprise to a data-centric view — a transition that requires R&D to streamline and adapt quickly to changing business processes.
Solutions such as E-WorkBook are making this task easier for researchers by changing the way data is captured, analyzed and reported, giving them flexibility in how they run their scientific experiments and reducing their time to access data.
Glyn Williams, VP of product delivery at IDBS, said: E-WorkBook continues to set the standard for ELNs and with this new version we once again raise the bar for functionality, speed and flexibility.
E-WorkBook has been deployed in R&D organizations across many industries and every day enables thousands of users to see more productive research and realize results faster. IDBS is committed to continually investing in its world-class products to meet the evolving needs of our customers as they strive to accelerate and streamline their research efforts.